Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adults
Severe eosinophilia is a strong prognostic marker in both children and adults, associated with malignancy, autoimmune and thromboembolic disease, and premature death. Recognition of SE should prompt comprehensive evaluation and close follow-up in general and specialty caregivers.
Authors
- Elbirt Daniel
- Vered Shkalim Zemer (ORCID: https://orcid.org/0000-0003-1733-5395)
- Shay Nemet (ORCID: https://orcid.org/0000-0002-6198-5099)
- Aviv Talmon
- Ramon Cohen (ORCID: https://orcid.org/0000-0001-5615-4066)
- Yuval Tal (ORCID: https://orcid.org/0000-0002-3633-2520)
- Limor Rubin (ORCID: https://orcid.org/0000-0001-5435-9420)
- Yaarit Ribak
- Keren Mahlab-Guri
- Ilan Asher
- Ruslan Sergienko
- Nur Sagi
- Oded Shamriz
- Inon Sarig
- Eyal Ben-Dori
Institutions
- Ben-Gurion University of the Negev (IL)
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
- Kaplan Medical Center (IL)
- Concern Foundation (US)
- Teva Pharmaceuticals (Israel) (IL)
- Geha Mental Health Center (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1016/j.jacig.2026.100654
- Primary Topic
- Eosinophilic Disorders and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 0.00